An inducible RIPK3-driven necroptotic system enhances cancer cell–based immunotherapy and ensures safety
Kok‐Siong Chen(Brigham and Women's Hospital), Khalid Shah(Harvard University)
Cited by 11
Related Papers
Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
|Proceedings of the National Academy of Sciences|2009|454
MicroRNA-21 Knockdown Disrupts Glioma Growth <i>In vivo</i> and Displays Synergistic Cytotoxicity with Neural Precursor Cell–Delivered S-TRAIL in Human Gliomas
|Cancer Research|2007|407
Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
|Cancer Discovery|2014|251
Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types
|Nature Communications|2020|159
Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticles
|Nature Nanotechnology|2025|21